Effects of a neurotensin analogue (PD149163) and antagonist (SR142948A) on the scopolamine-induced deficits in a novel object discrimination task

Behavioural Pharmacology

Volumn 17, Issue 4, 2006, Pages 357-362

  Azmi, Norazrina ^a   Norman, Christine ^b   Spicer, Clare H ^c   Bennett, Geoffrey W ^c  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^b NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Cholinergic pathways; Memory; Neurotensin; PD149163; Rat; SR142948A

Indexed keywords

2 [5 (2,6 DIMETHOXYPHENYL) 1 [4 [N (3 DIMETHYLAMINOPROPYL) N METHYLCARBAMOYL] 2 ISOPROPYLPHENYL] 1H PYRAZOL 3 YLCARBONYLAMINO]ADAMANTANE 2 CARBOXYLIC ACID; MUSCARINIC RECEPTOR BLOCKING AGENT; NEUROPEPTIDE; NEUROTENSIN; NEUROTENSIN DERIVATIVE; NEUROTENSIN RECEPTOR ANTAGONIST; PD 149163; SCOPOLAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CHOLINERGIC SYSTEM; COGNITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; MALE; MEMORY; NONHUMAN; RAT; WORKING MEMORY;

ADAMANTANE; ANIMALS; BRAIN; DEPRESSION, CHEMICAL; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; FORM PERCEPTION; IMIDAZOLES; INJECTIONS, INTRAVENTRICULAR; MALE; MEMORY, SHORT-TERM; MUSCARINIC ANTAGONISTS; NEUROTENSIN; RATS; RECEPTORS, NEUROTENSIN; SCOPOLAMINE; SPACE PERCEPTION;

EID: 33747456246     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fbp.0000224382.63744.20     Document Type: Article

References (42)

1. Alonso A, Faure MP, Beaudet A (1994). Neurotensin promotes oscillatory bursting behavior and is internalized in basal forebrain cholinergic neurons. J Neurosci 14:5778-5792.
2. Beninger RJ, Jhamandas K, Boegman RJ, el-Defrawy SR (1986). Effects of scopolamine and unilateral lesions of the basal forebrain on T-maze spatial discrimination and alternation in rats. Pharmacol Biochem Behav 24:1353-1360.
3. Besheer J, Short KR, Bevins RA (2001). Dopaminergic and cholinergic antagonism in a novel-object detection task with rats. Behav Brain Res 126:211-217.
4. 3H]SR 142948A, in the rat brain. Eur J Pharmacol 343:67-77.
5. Castia P, Marchesea G, Casua G, Ruiua S, Pani L (2004). Blockade of neurotensin receptors affects differently hypo-locomotion and catalepsy induced by haloperidol in mice. Neuropharmacol 47:128-135.
6. Carraway R, Leeman SE (1973). The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J Biol Chem 248:6854-6861.
7. Carraway R, Leeman SE (1976). Characterization of radioimmunoassayable neurotensin in the rat. Its differential distribution in the central nervous system, small intestine, and stomach. J Biol Chem 251:7045-7052.
8. Emson PC, Goedert M, Horsfield P, Rioux F, St Pierre S (1982). The regional distribution and chromatographic characterisation of neurotensin-like immunoreactivity in the rat central nervous system. J Neurochem 38:992-999.
9. Ennaceur A, Delacour J (1988). A new one-trial test for neurobiological studies of memory in rats I: behavioral data. Behav Brain Res 31:47-59.
10. Ennaceur A, Meliani K (1992). Effects of physostigmine and scopolamine on rats' performances in object-recognition and radial-maze tests. Psychopharmacology (Berlin) 109:321-330.
11. Ennaceur A, Cavoy A, Costa JC, Delacour J (1989). A new one-trial test for neurobiological studies of memory in rats. II: effects of piracetam and pramiracetam. Behav Brain Res 33:197-207.
12. Feifel D, Reza TL, Wustrow DJ, Davis MD (1999). Novel antipsychotic-like effects on prepulse inhibition of startle produced by a neurotensin agonist. J Pharmacol Exp Ther 288:710-713.
13. Gully D, Canton M, Boigegrain R, Jeanjean F, Molimard JC, Poncelet M, et al. (1993). Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. Proc Natl Acad Sci USA 90:65-69.
14. Gully D, Labeeuw B, Boigegrain R, Oury-Donat F, Bachy A, Poncelet M, et al. (1997). Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist. J Pharmacol Exp Ther 280:802-812.
15. Jay TM (2003). Dopamine: a potential substrate for synaptic plasticity and memory mechanisms. Prog Neurobiol 69:375-390.
16. 6 receptor antagonists reverse delay-dependent deficits in Novel Object Discrimination by enhancing consolidation - an effect sensitive to NMDA receptor antagonism. Neuropharmacology 47:195-204.
17. Kinkead B, Nemeroff CB (2002). Neurotensin: an endogenous antipsychotic? Curr Opin Pharmacol 2:99-103.
18. Klimesch W (1999). EEG alpha and theta oscillations reflect cognitive and memory performance: a review and analysis. Brain Res Rev 29:169-195.
19. Kornecook TJ, Kippin TE, Pinel JP (1999). Basal forebrain damage and objectrecognition in rats. Behav Brain Res 98:67-76.
20. Manberg PJ, Youngblood WW, Nemeroff CB, Rossor MN, Iversen LL, Prange AJ Jr, Kizer JS (1982). Regional distribution of neurotensin in human brain. J Neurochem 38:1777-1780.
21. Matthews RT (1999). Neurotensin depolarizes cholinergic and a subset of noncholinergic septal/diagonal band neurons by stimulating neurotensin-1 receptors. Neuroscience 94:775-783.
22. Morin AJ, Beaudet A (1998). Origin of the neurotensinergic innervation of the rat basal forebrain studied by retrograde transport of cholera toxin. J Comp Neurol 391:30-41.
23. Morin AJ, Tajani M, Jones BE, Beaudet A (1996). Spatial relationship between neurotensinergic axons and cholinergic neurons in the rat basal forebrain: a light microscopic study with three-dimensional reconstruction. J Chem Neuroanat 10:147-156.
24. Nakachi N, Yamada M, Cho T, Coleman NJ, Yamada M, Richelson E (1995). Expression of mRNA for neurotensin in rat brain cholinergic neurons. Biol Psychiatry 37:642.
25. Nemeroff CB, Luttinger D, Prange AJ Jr (1980). Neurotensin: central nervous system effects of a neuropeptide. Trends Neurosci 3:212-215.
26. Nemeroff CB, Luttinger D, Hernandez DE, Mailman RB, Mason GA, Davis SD, et al. (1983). Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies. J Pharmacol Exp Ther 225:337-345.
27. Paxinos G, Watson C (1986). The rat brain in Stereotaxic coordinates. 2nd ed. San Diego: Academic Press.
28. Petrie KA, Bubser M, Casey CD, Davis MD, Roth BL, Deutch AY (2004). The neurotensin agonist PD149163 increases Fos expression in the prefrontal cortex of the rat. Neuropsychopharmacology 29:1878-1888.
29. Prange AJ Jr, Nemeroff CB, Bissette G, Manberg PJ, Osbahr AJ III, Burnett GB, et al. (1979). Neurotensin: distribution of hypothermic response in mammalian and submammalian vertebrates. Pharmacol Biochem Behav 11:473-477.
30. Rakovska A, Giovannini MG, Della Corte L, Kalfin R, Bianchi L, Pepeu G (1998). Neurotensin modulation of acetylcholine and GABA release from the rat hippocampus: an in vivo microdialysis study. Neurochem Int 33:335-340.
31. Sakamoto N, Michel JP, Kiyama H, Tohyama M, Kopp N, Pearson J (1986). Neurotensin immunoreactivity in the human cingulate gyrus, hippocampal subiculum and mammillary bodies. Its potential role in memory processing. Brain Res 375:351-356.
32. Shibata K, Furukawa T (1988). The mammillary body, a potential site of action of neurotensin in passive avoidance behavior in rats. Brain Res 443:117-124.
33. Shilling PD, Richelson E, Feifel D (2003). The effects of systemic NT69L, a neurotensin agonist, on baseline and drug-disrupted prepulse inhibition. Behav Brain Res 143:7-14.
34. 2A and an alpha1 agonist. Psychopharmacology (Berlin) 175:353-359.
35. Szigethy E, Beaudet A (1987). Selective association of neurotensin receptors with cholinergic neurons in the rat basal forebrain. Neurosci Lett 83:47-52.
36. Szigethy E, Quirion R, Beaudet A (1990). Distribution of 125I-neurotensin binding sites in human forebrain: comparison with the localization of acetylcholinesterase. J Comp Neurol 297:487-498.
37. Uhl GR, Snyder SH (1976). Regional and subcellular distributions of brain neurotensin. Life Sci 19:1827-1832.
38. van Wimersma Greidanus TB, van Praag MC, Kalmann R, Rinkel GJ, Croiset G, Hoeke EC, et al. (1982). Behavioral effects of neurotensin. Ann N Y Acad Sci 400:319-329.
39. Warburton EC, Koder T, Cho K, Massey PV, Duguid G, Barker GR, et al. (2003). Cholinergic neurotransmission is essential for perirhinal cortical plasticity and recognition memory. Neuron 38:987-996.
40. Wasuntarawat C, Roe CH, Beckett SRG, Bennett GW (2001). Neurotensin reversed spatial and non-spatial working memory deficits induced by scopolamine. Behav Pharmacol 12(Suppl 1):S109.
41. 6 receptor antagonist, Ro 04-6790. Psychopharmacology (Berlin) 170:358-367.
42. Yamada M, Richelson E, Yamada M (1995). Heterogeneity of melanized neurons expressing neurotensin receptor messenger RNA in the substantia nigra and the nucleus paranigralis of control and Parkinson's disease brain. Neuroscience 64:405-417.